Status:
COMPLETED
Intestinal Biomarker Analysis After ECP for ICI Colitis
Lead Sponsor:
University of Freiburg
Conditions:
Colitis
Immune Checkpoint Inhibitor-Related Colitis
Eligibility:
All Genders
18+ years
Brief Summary
It was previously shown that ICI-colitis can be treated with extracorporeal photophoresis. Therefore this retrospective analysis is launched to study the chnages of immune cells in the peripheral bloo...
Detailed Description
It was previously shown that ICI-colitis can be treated with extracorporeal photophoresis. Therefore this retrospective analysis is launched to study the changes of immune cells in the peripheral bloo...
Eligibility Criteria
Inclusion
- ICI colitis
Exclusion
- no informed consent
Key Trial Info
Start Date :
July 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 30 2024
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06074874
Start Date
July 1 2023
End Date
March 30 2024
Last Update
April 3 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Freiburg University Medical Center
Freiburg im Breisgau, Baden-Wurttemberg, Germany, 79106